ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2026-01-21 01:47Group 1 - The core point of the news is that Zhongsheng Pharmaceutical's stock price has dropped by 5.26%, currently trading at 20.90 CNY per share, with a total market capitalization of 17.764 billion CNY [1] - Zhongsheng Pharmaceutical, established on December 31, 2001, and listed on December 11, 2009, is primarily engaged in the research, production, and sales of pharmaceuticals [1] - The company's revenue composition includes 53.03% from traditional Chinese medicine sales, 38.12% from chemical drug sales, 6.13% from Chinese medicinal materials and decoction pieces, 2.14% from raw materials and intermediates, and 0.58% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Taixin Fund has a significant position in Zhongsheng Pharmaceutical, with Taixin Smart Quantitative Stock Mixed Fund A (013033) holding 15,000 shares, accounting for 1.94% of the fund's net value [2] - The estimated floating loss for the fund today is approximately 17,400 CNY [2] - Taixin Smart Quantitative Stock Mixed Fund A (013033) was established on May 22, 2025, with a current scale of 12.5156 million CNY and a year-to-date return of 8.16%, ranking 1626 out of 8844 in its category [2]